• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在M期到G1期转换时,p110α的活性对于细胞增殖以及重新进入细胞周期至关重要。

p110α activity at the M-to-G1 transition is critical for cellular proliferation and reentry into the cell cycle.

作者信息

Çizmecioğlu Onur

机构信息

Department of Molecular Biology and Genetics, Science Faculty, İhsan Doğramacı Bilkent University, Ankara, Turkey.

出版信息

Turk J Biol. 2022 Feb 8;46(3):207-215. doi: 10.55730/1300-0152.2609. eCollection 2022.

DOI:10.55730/1300-0152.2609
PMID:37529255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10388040/
Abstract

Phosphoinositide 3-kinase (PI3K) signaling pathway is essential for normal physiology and is impaired in diseases such as premalignant hyperproliferative disorders, primary immunodeficiency, metabolic disorders, and cancer. Although the core PI3K pathway components are known today, a long-standing gap in our knowledge of PI3K signaling concerns how distinct PI3K isoforms and their activity patterns contribute to the functional consequences of pathway upregulation. In order to address this issue, we devised a molecular genetic cell model, which allowed temporal regulation of the indispensable PI3K isoform, p110α in distinct stages of the cell cycle. We found that late M and early G1 presence of p110α is key for proper cell cycle progression, whereas its S-phase abundance was redundant. Our results also emphasize a critical dependence of cell cycle reentry on early G1 activity of p110α. Collectively, our findings provide a temporal perspective to p110α activation and offer insight into which wave of PI3K activity could be essential for cell cycle progression.

摘要

磷酸肌醇-3激酶(PI3K)信号通路对正常生理功能至关重要,而在诸如癌前增生性疾病、原发性免疫缺陷、代谢紊乱和癌症等疾病中会受损。尽管如今已知PI3K信号通路的核心组成部分,但我们对PI3K信号传导的长期认知空白在于不同的PI3K亚型及其活性模式如何导致通路上调的功能后果。为了解决这个问题,我们设计了一种分子遗传细胞模型,该模型能够在细胞周期的不同阶段对不可或缺的PI3K亚型p110α进行时间调控。我们发现,p110α在M期末期和G1早期的存在是细胞周期正常进展的关键,而其在S期的丰度则是多余的。我们的结果还强调了细胞周期重新进入对p110α早期G1活性的关键依赖性。总体而言,我们的研究结果为p110α激活提供了一个时间视角,并深入了解了哪一波PI3K活性可能对细胞周期进展至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/be767ab6dc79/turkjbiol-46-3-207f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/b846ecab9476/turkjbiol-46-3-207f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/53f9cf52d0d3/turkjbiol-46-3-207f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/267fc04116a2/turkjbiol-46-3-207f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/ff1b7495a313/turkjbiol-46-3-207f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/be767ab6dc79/turkjbiol-46-3-207f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/b846ecab9476/turkjbiol-46-3-207f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/53f9cf52d0d3/turkjbiol-46-3-207f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/267fc04116a2/turkjbiol-46-3-207f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/ff1b7495a313/turkjbiol-46-3-207f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ff/10388040/be767ab6dc79/turkjbiol-46-3-207f5.jpg

相似文献

1
p110α activity at the M-to-G1 transition is critical for cellular proliferation and reentry into the cell cycle.在M期到G1期转换时,p110α的活性对于细胞增殖以及重新进入细胞周期至关重要。
Turk J Biol. 2022 Feb 8;46(3):207-215. doi: 10.55730/1300-0152.2609. eCollection 2022.
2
Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase.磷酸肌醇3激酶p110α和p110β调节细胞周期进入,在G1期表现出不同的激活动力学。
Mol Cell Biol. 2008 Apr;28(8):2803-14. doi: 10.1128/MCB.01786-07. Epub 2008 Feb 19.
3
Dynamics of GFP-Fusion p110α and p110β Isoforms of PI3K Signaling Pathway in Normal and Cancer Cells.PI3K信号通路中GFP融合的p110α和p110β亚型在正常细胞和癌细胞中的动力学
J Cell Biochem. 2016 Dec;117(12):2864-2874. doi: 10.1002/jcb.25598. Epub 2016 Jun 3.
4
The phosphatidylinositol 3-kinase (PI3K) isoform dependence of tumor formation is determined by the genetic mode of PI3K pathway activation rather than by tissue type.肿瘤形成对磷脂酰肌醇3激酶(PI3K)亚型的依赖性取决于PI3K途径激活的遗传模式,而非组织类型。
J Virol. 2014 Sep;88(18):10673-9. doi: 10.1128/JVI.01409-14. Epub 2014 Jul 2.
5
Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.靶向PI3K p110α亚型可抑制髓母细胞瘤的增殖、化疗耐药性和迁移。
Clin Cancer Res. 2008 Nov 1;14(21):6761-9. doi: 10.1158/1078-0432.CCR-08-0385.
6
P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse.P110α 介导的组成性 PI3K 信号限制了 p110δ 选择性抑制在套细胞淋巴瘤中的疗效,尤其是在多次复发的情况下。
Blood. 2013 Mar 21;121(12):2274-84. doi: 10.1182/blood-2012-10-460832. Epub 2013 Jan 22.
7
Activity of any class IA PI3K isoform can sustain cell proliferation and survival.任何一类 IA 型 PI3K 同工酶的活性都能维持细胞的增殖和存活。
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11381-6. doi: 10.1073/pnas.0906461107. Epub 2010 Jun 7.
8
Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.运动及磷酸肌醇3激酶(p110α)信号通路在扩张型和肥厚型心肌病中的保护作用
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):612-7. doi: 10.1073/pnas.0606663104. Epub 2007 Jan 3.
9
Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte function.选择性抑制磷酸肌醇 3-激酶 p110α 可保留淋巴细胞功能。
J Biol Chem. 2013 Feb 22;288(8):5718-31. doi: 10.1074/jbc.M112.379446. Epub 2012 Dec 28.
10
Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function.新型亚型选择性磷酸肌醇3激酶抑制剂对自然杀伤细胞功能的影响。
PLoS One. 2014 Jun 10;9(6):e99486. doi: 10.1371/journal.pone.0099486. eCollection 2014.

本文引用的文献

1
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.美国食品药品监督管理局批准概要:Alpelisib 联合氟维司群用于治疗激素受体阳性、人表皮生长因子受体 2 阴性、PIK3CA 突变的、晚期或转移性乳腺癌患者。
Clin Cancer Res. 2021 Apr 1;27(7):1842-1849. doi: 10.1158/1078-0432.CCR-20-3652. Epub 2020 Nov 9.
2
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.PI3K/AKT/mTOR:在乳腺癌进展、耐药性和治疗中的作用。
Cancer Metastasis Rev. 2016 Dec;35(4):515-524. doi: 10.1007/s10555-016-9637-x.
3
Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss.
Rac1介导的PI3K/p110β膜筏定位是其被GPCRs激活或PTEN缺失所必需的。
Elife. 2016 Oct 4;5:e17635. doi: 10.7554/eLife.17635.
4
The PI3K/AKT Pathway as a Target for Cancer Treatment.PI3K/AKT 通路作为癌症治疗的靶点。
Annu Rev Med. 2016;67:11-28. doi: 10.1146/annurev-med-062913-051343. Epub 2015 Oct 14.
5
PP2A-mediated regulation of Ras signaling in G2 is essential for stable quiescence and normal G1 length.PP2A介导的G2期Ras信号调节对于稳定静止和正常的G1期长度至关重要。
Mol Cell. 2014 Jun 19;54(6):932-945. doi: 10.1016/j.molcel.2014.04.023. Epub 2014 May 22.
6
Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4).Plk2 通过磷酸化介导的 Fbxw7(人 Cdc4)降解来调节中心体复制。
J Cell Sci. 2012 Feb 15;125(Pt 4):981-92. doi: 10.1242/jcs.095075. Epub 2012 Mar 7.
7
Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival.核而非胞质磷酸肌醇 3-激酶β在细胞存活中具有重要功能。
Mol Cell Biol. 2011 May;31(10):2122-33. doi: 10.1128/MCB.01313-10. Epub 2011 Mar 7.
8
Targeting the phosphoinositide 3-kinase pathway in cancer.靶向癌症中的磷酸肌醇3-激酶通路。
Nat Rev Drug Discov. 2009 Aug;8(8):627-44. doi: 10.1038/nrd2926.
9
Should individual PI3 kinase isoforms be targeted in cancer?在癌症治疗中是否应该针对单个PI3激酶亚型?
Curr Opin Cell Biol. 2009 Apr;21(2):199-208. doi: 10.1016/j.ceb.2008.12.007. Epub 2009 Feb 4.
10
Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.可视化多细胞细胞周期进程的时空动态变化。
Cell. 2008 Feb 8;132(3):487-98. doi: 10.1016/j.cell.2007.12.033.